Biophytis SA (BPTSY)
8.26
-0.01
(-0.12%)
USD |
OTCM |
May 17, 15:59
Biophytis Total Assets (Quarterly): 13.22M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.22M |
| June 30, 2023 | 15.88M |
| June 30, 2023 | 15.88M |
| December 31, 2022 | 23.58M |
| June 30, 2022 | 35.40M |
| June 30, 2022 | 35.40M |
| December 31, 2021 | 39.48M |
| June 30, 2021 | 42.53M |
| June 30, 2021 | 42.53M |
| December 31, 2020 | 33.47M |
| June 30, 2020 | 21.20M |
| Date | Value |
|---|---|
| June 30, 2019 | 16.86M |
| March 31, 2019 | 21.84M |
| June 30, 2018 | 24.61M |
| June 30, 2018 | 24.61M |
| December 31, 2017 | 31.13M |
| June 30, 2017 | 11.75M |
| June 30, 2017 | 11.75M |
| December 31, 2016 | 8.873M |
| June 30, 2016 | 12.45M |
| June 30, 2016 | 12.45M |
| December 31, 2015 | 14.81M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
13.22M
Minimum
Dec 2023
42.53M
Maximum
Jun 2021
27.95M
Average
28.52M
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 334.27M |
| Genfit SA | 192.20M |
| Edap TMS SA | 101.20M |
| Adaptimmune Therapeutics PLC | 258.01M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.52M |
| Shareholders Equity (Quarterly) | -4.264M |